• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组痘苗病毒感染后,抗CD40刺激的人B细胞对内源性病毒肽表位的呈递

Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection.

作者信息

Khanna R, Jacob C A, Burrows S R, Moss D J

机构信息

Queensland Institute of Medical Research, Bancroft Centre, Herston, Brisbane, Australia.

出版信息

J Immunol Methods. 1993 Aug 26;164(1):41-9. doi: 10.1016/0022-1759(93)90274-b.

DOI:10.1016/0022-1759(93)90274-b
PMID:7689619
Abstract

Cytotoxic T lymphocytes (CTLs) recognising viral antigens are an important host defence mechanism in restricting the proliferation of virus-infected cells. Previously, lymphoblastoid cell lines (LCLs) infected with vaccinia recombinants encoding viral proteins have been used to identify specific CTL epitopes. However, to localise the EBV CTL epitopes encoded by Epstein-Barr virus (EBV) transformants, LCLs are an inappropriate host for vaccinia recombinants. In the present study, an alternative host cell for vaccinia infection is described. Initial studies demonstrated that anti-CD40 stimulated human B cells replicated vaccinia virus and expressed EBV nuclear antigen(s) (EBNA) following infection with recombinant vaccinia encoding the appropriate region of the EBV genome. Recombinant vaccinia-infected anti-CD40 stimulated B cell lines were then used to localise target epitopes for a panel of EBV-specific CTL clones. Most importantly, in vitro stimulation of unfractionated mononuclear cells with recombinant vaccinia-infected anti-CD40 B cells activated a memory CTL response. Based on the vaccinia results, screening of peptides from EBNA6 defined the epitope for the EBNA6-specific CTL clones to the sequence KEHVIQNAFRK. This work clearly demonstrates that anti-CD40 stimulated B cell lines not only provide an efficient tool for localising CTL epitopes but also presents an alternative mechanism of reactivating a memory T cell response to any gene product expressed by recombinant vaccinia.

摘要

识别病毒抗原的细胞毒性T淋巴细胞(CTL)是限制病毒感染细胞增殖的重要宿主防御机制。此前,已使用感染了编码病毒蛋白的痘苗重组体的淋巴母细胞系(LCL)来鉴定特定的CTL表位。然而,对于定位由爱泼斯坦-巴尔病毒(EBV)转化体编码的EBV CTL表位而言,LCL并非痘苗重组体的合适宿主。在本研究中,描述了一种用于痘苗感染的替代宿主细胞。初步研究表明,抗CD40刺激的人B细胞在感染编码EBV基因组适当区域的重组痘苗后可复制痘苗病毒并表达EBV核抗原(EBNA)。然后,将重组痘苗感染的抗CD40刺激的B细胞系用于定位一组EBV特异性CTL克隆的靶表位。最重要的是,用重组痘苗感染的抗CD40 B细胞对未分离的单核细胞进行体外刺激可激活记忆CTL反应。基于痘苗实验结果,对来自EBNA6的肽段进行筛选,确定了EBNA6特异性CTL克隆的表位为序列KEHVIQNAFRK。这项工作清楚地表明,抗CD40刺激的B细胞系不仅为定位CTL表位提供了一种有效的工具,而且还提出了一种重新激活对重组痘苗表达的任何基因产物的记忆T细胞反应的替代机制。

相似文献

1
Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection.重组痘苗病毒感染后,抗CD40刺激的人B细胞对内源性病毒肽表位的呈递
J Immunol Methods. 1993 Aug 26;164(1):41-9. doi: 10.1016/0022-1759(93)90274-b.
2
Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.重组痘苗病毒感染后抗IgM刺激的B细胞中爱泼斯坦-巴尔病毒核抗原的表达及其被人细胞毒性T细胞识别的情况。
Immunology. 1991 Nov;74(3):504-10.
3
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.利用重组痘苗病毒定位爱泼斯坦-巴尔病毒细胞毒性T细胞表位:对疫苗开发的意义
J Exp Med. 1992 Jul 1;176(1):169-76. doi: 10.1084/jem.176.1.169.
4
Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.针对 Epstein-Barr 病毒(EBV)转化的 B 淋巴母细胞系产生的、受 I 类主要组织相容性复合体限制的细胞毒性 T 淋巴细胞。 这些细胞毒性 T 淋巴细胞对它们所针对的 EBV 转化的 B 淋巴母细胞系具有特异性。
J Exp Med. 1995 Jun 1;181(6):2221-8. doi: 10.1084/jem.181.6.2221.
5
Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.不同的HLA - B27亚型呈现相同的免疫显性爱泼斯坦 - 巴尔病毒肽。
J Exp Med. 1993 Sep 1;178(3):879-87. doi: 10.1084/jem.178.3.879.
6
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.利用重组痘苗病毒证明的针对爱泼斯坦-巴尔病毒核抗原的人细胞毒性T细胞反应。
Proc Natl Acad Sci U S A. 1990 Apr;87(8):2906-10. doi: 10.1073/pnas.87.8.2906.
7
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).EB病毒核抗原3(EBNA 3)中的一种爱泼斯坦-巴尔病毒特异性细胞毒性T细胞表位。
J Exp Med. 1990 Jan 1;171(1):345-9. doi: 10.1084/jem.171.1.345.
8
Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.从健康血清阳性个体中分离出对爱泼斯坦-巴尔病毒核抗原1肽表位具有特异性的细胞毒性T淋巴细胞:对病毒持续存在和肿瘤监测的意义。
Virology. 1995 Dec 20;214(2):633-7. doi: 10.1006/viro.1995.0076.
9
A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.一种表达爱泼斯坦-巴尔病毒(EBV)靶抗原的重组腺病毒能够在体外选择性地重新激活EBV细胞毒性T淋巴细胞记忆中的罕见成分。
J Virol. 1996 Apr;70(4):2394-402. doi: 10.1128/JVI.70.4.2394-2402.1996.
10
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.鉴定人类细胞毒性T细胞对爱泼斯坦-巴尔病毒(EBV)反应的靶抗原:对EBV阳性恶性肿瘤免疫控制的意义。
J Exp Med. 1992 Jul 1;176(1):157-68. doi: 10.1084/jem.176.1.157.

引用本文的文献

1
Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.对人巨细胞病毒的CD8 + T细胞反应的体外分析揭示了健康病毒携带者中广泛且多特异性的反应性。
J Virol. 2003 May;77(9):5226-40. doi: 10.1128/jvi.77.9.5226-5240.2003.
2
Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.将包含多个II类限制性病毒表位的多表位蛋白靶向分泌/内吞途径可促进CD4 + 细胞毒性T淋巴细胞的免疫识别:一种疫苗设计的新方法。
J Virol. 1998 Mar;72(3):2246-52. doi: 10.1128/JVI.72.3.2246-2252.1998.
3
Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.
不同地理来源的爱泼斯坦-巴尔病毒分离株中基因变异的进化动力学:免疫压力非依赖性基因漂变的证据
J Virol. 1997 Nov;71(11):8340-6. doi: 10.1128/JVI.71.11.8340-8346.1997.
4
Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.携带 HLA 等位基因不同亚型个体中 Epstein-Barr 病毒特异性细胞毒性 T 细胞反应的层次结构:对基于表位的抗病毒疫苗的意义。
J Virol. 1997 Oct;71(10):7429-35. doi: 10.1128/JVI.71.10.7429-7435.1997.
5
Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants.针对免疫显性表位的细胞毒性T淋巴细胞克隆对自然发生的爱泼斯坦-巴尔病毒变体表现出有识别能力的拮抗反应。
J Virol. 1996 Oct;70(10):7306-11. doi: 10.1128/JVI.70.10.7306-7311.1996.
6
Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.肽转运体(TAP-1和TAP-2)非依赖性的爱泼斯坦-巴尔病毒(EBV)潜伏膜蛋白2A的内源性加工:对EBV相关恶性肿瘤细胞毒性T淋巴细胞控制的影响
J Virol. 1996 Aug;70(8):5357-62. doi: 10.1128/JVI.70.8.5357-5362.1996.
7
Immune regulation in Epstein-Barr virus-associated diseases.爱泼斯坦-巴尔病毒相关疾病中的免疫调节
Microbiol Rev. 1995 Sep;59(3):387-405. doi: 10.1128/mr.59.3.387-405.1995.
8
Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.重组多表位蛋白中表达的最小表位被加工并呈递给CD8+细胞毒性T细胞:对疫苗设计的启示。
Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5845-9. doi: 10.1073/pnas.92.13.5845.